[1] 彭颖, 陈松华, 陈彬, 等.耐多药肺结核病人中断治疗的影响因素分析[J].预防医学, 2016, 28(10):977.
[2] SMITH SE, PRATT R, TRIEU L, et al.Epidemiology of pediatric multidrug-resistant tuberculosis in the United States, 1993-2014[J].Clin Infect Dis, 2017, 65(9):1437.
[3] SEIFERT M, GEORGHIOU SB, GARFEIN RS, et al.Impact of fluoroquinolone use on mortality among a cohort of patients with suspected drug-resistant tuberculosis[J].Clin Infect Dis, 2017, 65(5):772.
[4] 李振生, 李德新, 李春霞.多指标联合检测在菌阴肺结核诊断中的价值研究[J].中华保健医学杂志, 2017, 19(4):307.
[5] PANG Y, LU J, HUO FM, et al.Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China:a five-year review[J].J Infection, 2017, 75(5):433.
[6] 韦琳, 卢忠武, 罗英杰, 等.肺结核病人真菌感染的CT影像特点研究[J].中华医院感染学杂志, 2017, 27(17):3921.
[7] 马春燕, 石春雷, 韩勤, 等.初诊肺结核病人的生命质量及其影响因素研究[J].中华全科医学, 2017, 15(4):637.
[8] MOMIN MAM, SINHA S, TUCKER IG, et al.Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis[J].Int J Pharm, 2017, 528(1/2):107.
[9] 潘稚芬, 高跃中, 刘加良, 等.嘉兴市耐多药肺结核筛查结果分析[J].预防医学, 2016, 28(8):821.
[10] LESTARI BW, ANDRIYOKO B, HILL P, et al.Detection and treatment delay among drug-resistant tuberculosis patients in provincial hospital in Bandung, Indonesia[J].Trop Med Int Health, 2017, 22(5):364.
[11] 徐东芳, 王庆, 李孳, 等.安徽省420株结核分枝杆菌对一线和二线抗结核药物药敏结果分析[J].中国人兽共患病学报, 2014, 30(1):54.
[12] FURIN J, COX H.To test or not to test ending the age-old debate for drug-resistant tuberculosis[J].Clin Infect Dis, 2017, 65(7):1212.
[13] EBERS A.Determination of plasma levels of levofloxacin by high performance liquid chromatography for use at a multidrug-resistant tuberculosis hospital in tanzania[J].Am J Trop Med Hyg, 2017, 95(5):367.